Author:
Saxena A R,Chamarthi B,Williams G H,Hopkins P N,Seely E W
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Young WF Jr . Endocrine hypertension. In: Melmed S, Williams RH (eds). Williams Textbook of Endocrinology 12th ed Chapter 15. Elsevier/Saunders: Philadelphia, 505, (2011).
2. Goldstein DS . Plasma catecholamines in clinical studies of cardiovascular diseases. Acta Physiol Scand Suppl 1984; 527: 39–41.
3. Boldt J, Menges T, Kuhn D, Diridis C, Hempelmann G . Alterations in circulating vasoactive substances in the critically ill-a comparison between survivors and non-survivors. Intensive Care Med 1995; 21: 218–225.
4. Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 2003; 107 (9): 1278–1283.
5. Benedict CR, Shelton B, Johnstone DE, Francis G, Greenberg B, Konstam M et al. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators. Circulation 1996; 94 (4): 690–697.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献